Director of Gynecologic Oncology · Experience: Mount Sinai Medical Center Miami Beach · Education: UT MD Anderson Cancer Center · Location: Miami Beach Dr. Slomovitz Discusses a Study of Everolimus/Letrozole or Hormonal Therapy in Endometrial Cancer
On the Scene at #SGOMtg: Endometrial Cancer Research Highlights The annual European Hematology Association (EHA) meeting was successfully held both online and offline from June 8th to 11th, Brian M. Slomovitz, MD, on Cervical Cancer: Update on Tisotumab
Brian M. Slomovitz MD, MS Dr. Slomovitz on the Importance of Developing Sequencing Strategies in Endometrial Cancer
Welcome to OC 360 LIVE! In this Ask The Expert session Dr. David Gershenson discusses and answers questions on all things Brian M. Slomovitz, M.D., co-leader of the Gynecologic Cancers Site Disease Group at Sylvester Comprehensive Cancer Center, received the In patients with previously treated recurrent or metastatic cervical cancer, tisotumab vedotin-tftv was more efficacious than chemotherapy as second- or third-
The Pap Corps Awards Endowment to Dr. Ronan Swords Society of Gynecologic Oncology 50th Anniversary: John P. Curtin, MD Brian M Slomovitz, MD, MS, is the Sylvester Professor of Obstetrics and Gynecology and Human Genetics at the University of Miami.
John C. Araujo, MD, PhD, assistant professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The Gynecologic Oncology at ESMO Congress 2021: Phase 2 study in patients with R/M Cervical cancer Dr. Mario Leitao, Jr. Update on the Management of Cervical Cancer
Highlighting some of the endometrial cancer research presented at the SGO Annual Meeting, Brian Slomovitz, MD, from the Dr. Nimesh Nagarsheth on the Evolution of Gynecologic Oncology
OC 360 LIVE: Dr. David Gershenson Brian Slomovitz is Director of Gynecologic Oncology and Co-Chair of the Cancer Research Committee at Mount Sinai Medical Center. He is also a Professor of
Brian Slomovitz, MD, regarding the long term follow-up data on PARP inhibitors in ovarian cancer Gynecologic Robotic Surgery for Women's Cancer Mount Sinai's Dr. Nimesh Nagarsheth discusses the evolution of gynecologic oncology. Dr. Nagarsheth has performed extensive
Brian M. Slomivitz, MD, gynecologic oncologist, Sylvester Comprehensive Cancer Center, University of Miami, discusses GOG The Society of Gynecologic Oncology (SGO) celebrates 50 years of dedication to advancing the fight against women's Florida Panthers players visit patients at Sylvester Comprehensive Cancer Center
What if doctors could mitigate the impact of strokes by regenerating #neurological pathways? How about reducing the need for Just before the ceremony to award Dr. Ronan Swords "The Pap Corps Endowed Professorship in Leukemia", he and several
First Scarless Robotic Hysterectomy Patient Talks | Baptist Health South Florida Brian M. Slomovitz, MD, is the Director of Gynecologic Oncology and Co-Chair of the Cancer Research Committee at Mount Sinai Medical Center, Brian Slomovitz, MD, elaborates on the role of immunotherapy in ovarian cancer
Dr. Slomovitz, Professor of Obstetrics & Gynecology, Florida International University, Gynecologic Oncologist, Broward Health, The Pap Corps - Panel Interview with Drs. Swords, Jahanzeb, Zelent, and Slomovitz
A Guideline-based Care Model for Endometrial Cancer in the Adjuvant Setting Stop the Sniffles
IGCS President Rob Coleman and 2022 IGCS Program Chairs, Audrey Tsunoda and Brian Slomovitz share updates on this year's Dr. Elizabeth Nugent's presentation at Ovarcome's 2021 Annual Conference OVARCOMING CANCER. Dr. Slomovitz on Sequencing Strategies for Endometrial Cancer
Gynecologic oncology research at ASCO 2017: Nivolumab trial Let's Talk About #RareOvarianCancers #76 with #RareOvarianCancer Legend Dr. David Gershenson, Professor, MD Anderson Adjuvant Pembrolizumab for High-Risk, dMMR Endometrial Cancer
Join these gynecologic oncology experts in a live social media event to hear the latest endometrial cancer clinical practice Dr. Amanda Bruegl - Gynecology Oncology Fellow
Meet The Professors Live: Clinical Investigators Provide Perspectives on Actual Cases of Patients with Ovarian and Endometrial Journal Club: Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer
A Lake County family physician says that seasonal pollen is the price we pay for living in the Central Florida climate. Dr. Anielka IGCS 2022 New York City: I Am Going Investigating Immunotherapy and Chemotherapy in Endometrial
Our Masterclasses help you keep up to date with evolving medical practice and recent advances in the management of common Kathleen Moore, MD, from the University of Oklahoma Health Sciences Center in Oklahoma City, reviews research on the
Brian Slomovitz, MD, MS, FACOG (@drslomovitzgynonc) • Instagram Miami gynecologic oncologist Ricardo Estape, M.D., performed South Florida's first single-incision robotic hysterectomy in May at
Clinical Investigators Provide Perspectives on Cases of Patients with Ovarian and Endometrial Cancer Case Study: COVID-19 and Ovarian Cancer Dr Peter Boylan on what to expect at RCPI Masterclass in Obstetrics and Gynaecology 9 November 2016
Gynecologic Oncology at ESMO Congress 2021: Trial Study in Cervical Cancer Focusing on You: Brian M. Slomovitz, M.D. Dr. Slomovitz, Professor of Obstetrics and Gynecology, Florida International University, Gynecologic Oncologist, Broward Health,
Khilen Patel, MD, from the Medical College of Georgia at Augusta University in Augusta, GA, discusses "ABSTRACT 6: Palliative Care & Symptom Management in Ovarian Cancer
How Different Factors Affect Treatment of Endometrial Cancer Not These Ovaries Establishes Gynecologic Oncology Research Supervisor Program at Mount Sinai Dr. Amir Fathi Interprets the Latest Developments in Targeted Therapy for Acute Myeloid Leukemia
Listen to a new Journal Club with PI Dr. Brian Slomovitz and moderator Dr. Leslie Randall as they discuss details on the New Dr. Araujo on Importance of Bone-Targeting Agents in mCRPC
He is a national and global principal investigator on numerous clinical trials related to endometrial cancer, including trials investigating immunotherapy and Orthopaedic/Sports Medicine Surgeon - Brian McCall, M.D. Presence Health
Brian Slomovitz, MD, and Daniel Tobias, MD, discuss how robotic surgery can be used to perform laparoscopic hysterectomies Dr. Peter Khamvongsa On the Scene at #SGOMtg Disparities in GYN Cancer
Brian M. Slomovitz, MD, professor and chief in the Division of Gynecologic Oncology at the Sylvester Comprehensive Cancer, Sylvester Researcher Dr. Brian Slomovitz Receives Award for Best Lowdown on Low Grade Serous Ovarian Cancer: Learn The Latest
Women's Cancers in the Americas: Strategies for Synergy October 5th, 2016. Dr. Brian Slomovitz, director of gynecologic oncology at Sylvester Comprehensive Cancer Center, discusses use of a novel Brian M. Slomovitz, MD, discusses the role of surgery in women with endometrial cancer. Website:
Brian M. Slomovitz, MD, gynecologic oncologist, Sylvester Comprehensive Cancer Center, University of Miami, discusses GOG Sylvester Anthem OR Voices
Dr. Peter Khamvongsa has been using Rx Medical Web for Medical Internet Marketing, for years. PRIME® Faculty Biography - Brian M Slomovitz, MD, MS
Dr. Slomovitz is a specialist in clinical trial development, robotic surgery, sentinel lymph node evaluation, and immunotherapy. Society of Gynecologic Oncology 50th Anniversary: Melissa Schwartz, MD
As part of the National Hockey League's Hockey Fights Cancer initiative, members of the Florida Panthers players visit Sylvester Endometrial Cancer | Cases from the Community: Investigators Discuss Available Research Guiding t Mirza, M.D., Dana M. Chase, M.D., Brian M. Slomovitz, M.D., René dePont Christensen, Ph.D., Zoltán Novák, Ph.D., Destin Black, M.D., Lucy Gilbert, M.D., +
Brian Slomovitz, MD, on incorporating biomarker-driven therapy in ovarian cancer For the August 8, 2015 Vattikuti Scholar Webinar, Dr. Mario M. Leitao, Jr. was the guest lecturer. He practices in New York, NY at Case Study: Platinum Sensitive Recurrent High-Grade Serous Ovarian Cancer
Focusing on You: Immunotherapy for Gynecologic Cancer We Are Healers is a project of the Native American Center for Health Professions. Our goal is simple: grow Native health care WABC TV - Ovarian Cancer and Where to Seek Treatment
Brian M. Slomovitz, MD, discusses the importance of developing sequencing strategies in endometrial cancer treatment. Website: Gynecology Updates from ASCO 2017 - Dr. Brian Slomovitz
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer Dr. Shannon Westin and her guest, Dr. Brian Slomovitz discuss the article "Pembrolizumab or Placebo Plus Adjuvant David O'Malley, MD, a professor in the Department of Obstetrics and Gynecology at The Ohio State University Comprehensive
Brian M. Slomovitz, MD, professor and chief in the Division of Gynecologic Oncology, Sylvester Comprehensive Cancer Center, Dr. Brian Slomovitz, MD - Mount Sinai Medical Center Not These Ovaries is turning dollars into discovery by funding a dedicated Gynecologic Oncology Research Supervisor Program
Featuring perspectives from Drs Robert L Coleman, Matthew A Powell and Brian M Slomovitz, moderated by Dr Shannon N Dr. Brian M. Slomovitz is an obstetrician-gynecologist in Fort Lauderdale, Florida and is affiliated with multiple hospitals in the area.
Nicoletta Colombo, MD, PhD, from the European Institute of Oncology in Milan, Italy discusses in this video "Pembrolizumab plus Dr. Brian M. Slomovitz, MD | Fort Lauderdale, FL | Obstetrician To celebrate SGO's 50th Anniversary, past president Dr. John P. Curtin, MD shares his memory of his first SGO membership
Harnessing the Amazing Power of Stem Cells David O'Malley, MD, from Ohio State University and OSUCCC in Columbus, OH, discusses in this video the abstract "Balstilimab
Dr. Ronan Swords was awarded The Pap Corps Endowed Professorship in Leukemia by Dr. Stephen Nimer, Director of Sylvester GYN oncologists, Daniel Tobias, MD, director, Women's Cancer Center; and Brian Slomovitz, MD, director, oncology research, Dr. Brian Slomovitz. University of Miami/University of West Indies Gynecologic Oncology Fellowship
Dr. O'Malley on the Tolerability of PARP Inhibitors in Ovarian Cancer Brian Slomovitz - Director of Gynecologic Oncology | LinkedIn Dr. Slomovitz on the Role of Surgery in Endometrial Cancer